Showing results (51-60 of 163) with videos related to
Sort By:
Pageof 17
Human Toxicology|December 1, 1986
Charcoal-column haemoperfusion does not significantly enhance chlormethiazole removalR E Ferner, A Pottage, D W Ryan, et al.Journal of Neurology, Neurosurgery, and Psychiatry|April 15, 2000
Detailed analysis of the oligodendrocyte myelin glycoprotein gene in four patients with neurofibromatosis 1 and primary progressive multiple sclerosisM R Johnson, R E Ferner, M Bobrow, et al.Postgraduate Medical Journal|November 26, 2010
Republished paper: Where errors occur in the preparation and administration of intravenous medicines: a systematic review and Bayesian analysisSarah E McDowell, Shahrul Mt-Isa, Deborah Ashby, et al.Quality & Safety in Health Care|January 13, 2010
Where errors occur in the preparation and administration of intravenous medicines: a systematic review and Bayesian analysisSarah E McDowell, Shahrul Mt-Isa, Deborah Ashby, et al.Journal of Neurology, Neurosurgery, and Psychiatry|July 20, 2007
Cervical cord compression from plexiform neurofibromas in neurofibromatosis 1J R Leonard, R E Ferner, N Thomas, et al.Postgraduate Medical Journal|November 4, 1998
Pyrexia, anaemia and acute renal failure secondary to omeprazoleM J Landray, T Ringrose, R E Ferner, et al.Lancet (London, England)|July 8, 1989
Drugs in donated bloodR E Ferner, J A Dunstan, S Chaplin, et al.British Journal of Clinical Pharmacology|September 29, 2005
The quality of information on monitoring for haematological adverse drug reactionsR E Ferner, Jamie Coleman, Munir Pirmohamed, et al.Journal of Neurology, Neurosurgery, and Psychiatry|May 1, 1993
MRI in neurofibromatosis 1. The nature and evolution of increased intensity T2 weighted lesions and their relationship to intellectual impairmentR E Ferner, R Chaudhuri, J Bingham, et al.Journal of Clinical Pharmacy and Therapeutics|August 13, 2003
The safety of spironolactone treatment in patients with heart failureC Anton, A R Cox, R D S Watson, et al.Pageof 17